The European Chemicals Agency (ECHA) has provided a draft update of the Appendices to Chapters R.7a and R7.c of the Guidance on IR&CSA (Endpoint specific guidance) on “recommendations for nanomaterials” regarding human health endpoints. The Appendice have been sent for consultation to CARACAL (the Competent Authorities for REACH and CLP) who are now invited to comment upon it.
The deadline for the consultation is 24 March 2017.
The three draft appendices provide a number of updates on e.g. testing and sample preparation, advice on non-testing methods, considerations regarding lung-overload, repeated dose testing and update on mutagenicity.
An Exclusive NIA Member consultation (NIA Members only) is available for Members comments and input.